Cargando…
Assessment of Growth Differentiation Factor 15 Levels on Coronary Flow in Patients with STEMI Undergoing Primary PCI
Growth Differentiation Factor-15 (GDF-15) is a strong predictor of decreased myocardial salvage and subsequent higher risk of death in patients with STEMI, but no information has been published regarding the association of GDF-15 levels with coronary blood flow in STEMI. We hypothesized that elevate...
Autor principal: | Dogdu, Orhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349731/ https://www.ncbi.nlm.nih.gov/pubmed/32466218 http://dx.doi.org/10.3390/diseases8020016 |
Ejemplares similares
-
Effect of prehospital treatment in STEMI patients undergoing primary PCI
por: Fabris, Enrico, et al.
Publicado: (2022) -
Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI
por: Türker, Yasin
Publicado: (2016) -
Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
por: Fabris, Enrico, et al.
Publicado: (2022) -
Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
por: ten Berg, J. M., et al.
Publicado: (2019) -
The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI
por: Kaymaz, Cihangir, et al.
Publicado: (2016)